AI CuratorAI-generated

Research summary · 2 d ago

AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

N6-induced IL-10+ B Cells in Mice

N6 treatment led to over 95% of B cells expressing IL-10 and the transfer of these cells resulted in remission of experimental autoimmune encephalomyelitis. In mice, these B cells migrated to the CNS and became IL-10+ plasma cells. The therapeutic effect was lost in mice lacking IL-10 receptors in long-lived myeloid cells.

Tags: #MSResearch
Most relevant to: —
Source: Read original source (PMID 42838057)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

This research indicates that enhancing IL-10 expression in B cells could be a potential strategy for treating autoimmunity, specifically in the context of central nervous system conditions.

What this does not prove

The study does not demonstrate safety or efficacy in humans and is limited to animal models; the precise mechanism of N6 in human B cells remains unclear.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: Not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-10-06
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Primary evidenceInduced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. ↗DOI: 10.1016/j.immuni.2026.09.006

Supporting passages (5)

publication datePublication date: 2026-10-06

interventionN6-induced B cells accumulated in the central nervous system (CNS) and differentiated into IL-10+ plasma cells, promoting transcriptional and phenotypic changes in myeloid cells within the CNS.

primary endpointTransfer of IL-10+ B cells induced remission of experimental autoimmune encephalomyelitis.

findingsTransfer of IL-10+ B cells induced remission of experimental autoimmune encephalomyelitis.

limitationsTitle: Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.